Abstract
I conducted a detailed examination of the prescription rates of antiallergic agents, including oral and nasal preparations, prescribed for patients with Japanese cedar pollinosis in 2016, when there was little cedar pollen in the air, and in 2019, when the atmospheric levels of cedar pollen were much higher.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
